yl23455永利官网

洞察市场格局
解锁药品研发情报

免费客服电话

18983288589
医药数据查询

【ChiCTR2400081879】The mediating role of cognitive fusion, experiential avoidance, and low self-esteem in self-critical perfectionism and depression/anxiety: A randomized controlled trial on ACT-based program

基本信息
登记号

ChiCTR2400081879

试验状态

尚未开始

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2024-03-14

临床申请受理号

/

靶点

/

适应症

Anxiety, depression

试验通俗题目

The mediating role of cognitive fusion, experiential avoidance, and low self-esteem in self-critical perfectionism and depression/anxiety: A randomized controlled trial on ACT-based program

试验专业题目

The mediating role of cognitive fusion, experiential avoidance, and low self-esteem in self-critical perfectionism and depression/anxiety: A randomized controlled trial on ACT-based program

申办单位信息
申请人联系人
申请人名称
联系人邮箱
联系人邮编

联系人通讯地址
临床试验信息
试验目的

Study 1: - Provide a model to the existing understanding of the relationship between self-critical perfectionism and depression/anxiety as well as the underlying mechanisms. - Identify prominent factors such that intervention can be developed to mitigate self-critical perfectionists from developing depression/anxiety. Study 2: - Test the efficacy of Acceptance and Commitment Therapy (ACT) as a low-intensity early intervention for those at risk for depression and anxiety. - Conduct a focus group analysis on those high in self-critical perfectionism. - Examine the impact of therapeutic alliance on treatment effect. - Test the model as proposed in Study 1 with this longitudinal data.

试验分类
试验类型

随机平行对照

试验分期

其它

随机化

A research staff who is blinded to the study's design will randomly allocate the list of enrolled participants to either condition 1 (treatment group) or condition 2 (waitlist control) using Excel.

盲法

None

试验项目经费来源

/

试验范围

/

目标入组人数

84;420

实际入组人数

/

第一例入组时间

2023-12-01

试验终止时间

2025-12-31

是否属于一致性

/

入选标准

Study 1: Adults aged 18 or above. Study 2: Adults aged 18-65; people with at least mild level of depression or anxiety；

排除标准

Study 1: None Study 2: People with serious mental disorder; people with suicidal attempt within the past 6 months or scored 2 or above on item 9 of Patient Health Questionnaire (PHQ-9); people with active psychotic symptoms; people receiving active psychological intervention；

研究者信息
研究负责人姓名
试验机构

University of Hong Kong

研究负责人电话
研究负责人邮箱
研究负责人邮编

/

联系人通讯地址

University of Hong Kong的其他临床试验

更多

University of Hong Kong的其他临床试验

更多

最新临床资讯

yl23455永利官网企业版
50亿+条医药数据随时查
7天免费试用
体验产品